Yifan Pharmaceutical Statistics
Total Valuation
SHE:002019 has a market cap or net worth of CNY 13.14 billion. The enterprise value is 14.47 billion.
Market Cap | 13.14B |
Enterprise Value | 14.47B |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
Earnings Date | Apr 28, 2025 |
Ex-Dividend Date | Sep 25, 2024 |
Share Statistics
SHE:002019 has 1.22 billion shares outstanding. The number of shares has decreased by -1.37% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.22B |
Shares Change (YoY) | -1.37% |
Shares Change (QoQ) | +4.76% |
Owned by Insiders (%) | 41.84% |
Owned by Institutions (%) | 9.19% |
Float | 707.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 26.02 |
PS Ratio | 2.64 |
PB Ratio | 1.54 |
P/TBV Ratio | 3.30 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.44, with an EV/FCF ratio of -194.45.
EV / Earnings | -43.64 |
EV / Sales | 2.90 |
EV / EBITDA | 32.44 |
EV / EBIT | 95.61 |
EV / FCF | -194.45 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.30.
Current Ratio | 1.32 |
Quick Ratio | 0.89 |
Debt / Equity | 0.30 |
Debt / EBITDA | 5.62 |
Debt / FCF | -33.71 |
Interest Coverage | 2.16 |
Financial Efficiency
Return on equity (ROE) is -7.68% and return on invested capital (ROIC) is 0.86%.
Return on Equity (ROE) | -7.68% |
Return on Assets (ROA) | 0.77% |
Return on Invested Capital (ROIC) | 0.86% |
Return on Capital Employed (ROCE) | 1.61% |
Revenue Per Employee | 1.18M |
Profits Per Employee | -78,378 |
Employee Count | 4,230 |
Asset Turnover | 0.40 |
Inventory Turnover | 2.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.09% in the last 52 weeks. The beta is 0.98, so SHE:002019's price volatility has been similar to the market average.
Beta (5Y) | 0.98 |
52-Week Price Change | +7.09% |
50-Day Moving Average | 11.17 |
200-Day Moving Average | 11.89 |
Relative Strength Index (RSI) | 52.18 |
Average Volume (20 Days) | 9,165,831 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002019 had revenue of CNY 5.00 billion and -331.54 million in losses. Loss per share was -0.27.
Revenue | 5.00B |
Gross Profit | 2.28B |
Operating Income | 151.32M |
Pretax Income | -618.74M |
Net Income | -331.54M |
EBITDA | 427.90M |
EBIT | 151.32M |
Loss Per Share | -0.27 |
Balance Sheet
The company has 1.08 billion in cash and 2.51 billion in debt, giving a net cash position of -1.43 billion or -1.17 per share.
Cash & Cash Equivalents | 1.08B |
Total Debt | 2.51B |
Net Cash | -1.43B |
Net Cash Per Share | -1.17 |
Equity (Book Value) | 8.42B |
Book Value Per Share | 7.00 |
Working Capital | 942.35M |
Cash Flow
In the last 12 months, operating cash flow was 444.54 million and capital expenditures -518.95 million, giving a free cash flow of -74.41 million.
Operating Cash Flow | 444.54M |
Capital Expenditures | -518.95M |
Free Cash Flow | -74.41M |
FCF Per Share | -0.06 |
Margins
Gross margin is 45.73%, with operating and profit margins of 3.03% and -6.64%.
Gross Margin | 45.73% |
Operating Margin | 3.03% |
Pretax Margin | -12.38% |
Profit Margin | -6.64% |
EBITDA Margin | 8.56% |
EBIT Margin | 3.03% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.86%.
Dividend Per Share | 0.20 |
Dividend Yield | 1.86% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 1.37% |
Shareholder Yield | 3.24% |
Earnings Yield | -2.52% |
FCF Yield | -0.57% |
Stock Splits
The last stock split was on May 16, 2016. It was a forward split with a ratio of 2.5.
Last Split Date | May 16, 2016 |
Split Type | Forward |
Split Ratio | 2.5 |
Scores
SHE:002019 has an Altman Z-Score of 3.42.
Altman Z-Score | 3.42 |
Piotroski F-Score | n/a |